Stay updated on PEMSYS: Pembrolizumab Modulation Clinical Trial

Sign up to get notified when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEMSYS: Pembrolizumab Modulation Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:24:54.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Updated revision from v3.4.1 to v3.4.2; no visible changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:06:35.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no substantive changes to content or functionality are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:17:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.3%
    Check dated 2026-01-28T05:00:56.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    - Revision updated from v3.3.3 to v3.3.4; no changes to the study data, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-01-14T03:03:18.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T20:36:13.000Z thumbnail image

Stay in the know with updates to PEMSYS: Pembrolizumab Modulation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEMSYS: Pembrolizumab Modulation Clinical Trial page.